ARTICLE | Company News
Axxima, Qiagen deal
May 13, 2002 7:00 AM UTC
The companies will develop oligonucleotide probes to identify differentially regulated protein kinases and phosphatases. Axxima, which will contribute technology related to human protein kinases and p...